Clinical Trial Update: A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism [Phase 3]

View source ↗

Summary

This update describes a Phase 3 clinical trial evaluating Ersodetug for tumor hyperinsulinism, which is currently in recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor Hyperinsulinism

Drugs mentioned

• Ersodetug (ersodetug)

Snippet

Sponsor: Rezolute | Conditions: Tumor Hyperinsulinism (Tumor HI) | Phase 3 | Status: RECRUITING